Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 2
2004 1
2006 3
2009 1
2010 3
2011 2
2012 3
2013 1
2014 2
2015 2
2016 1
2017 2
2018 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Oligoastrocytic tumor"
Page 1
Oligodendroglial tumors.
Chowdhary S, Chamberlain MC. Chowdhary S, et al. Expert Rev Neurother. 2006 Apr;6(4):519-32. doi: 10.1586/14737175.6.4.519. Expert Rev Neurother. 2006. PMID: 16623651 Review.
Oligodendroglial tumors are classified as being low-grade oligodendroglial tumors, high-grade anaplastic oligodendroglial tumors or mixed oligo-astrocytic tumors. The mixed tumors can again be low-grade or high-grade. The recent European Organiz …
Oligodendroglial tumors are classified as being low-grade oligodendroglial tumors, high-grade anaplastic oligodendroglial t …
Prognostic factors for low-grade gliomas.
Stupp R, Janzer RC, Hegi ME, Villemure JG, Mirimanoff RO. Stupp R, et al. Semin Oncol. 2003 Dec;30(6 Suppl 19):23-8. doi: 10.1053/j.seminoncol.2003.11.029. Semin Oncol. 2003. PMID: 14765381 Review.
Low-grade gliomas are a heterogenous group of diseases characterized by relatively slow-growing primary brain tumors of astrocytic and/or oligodendroglial origin. Many patients present with easily controlled seizures and remain stable for years, whereas others progress rap …
Low-grade gliomas are a heterogenous group of diseases characterized by relatively slow-growing primary brain tumors of astrocytic an …
Population-based incidence and survival of central nervous system (CNS) malignancies in Girona (Spain) 1994-2005.
Fuentes-Raspall R, Vilardell L, Perez-Bueno F, Joly C, Garcia-Gil M, Garcia-Velasco A, Marcos-Gragera R. Fuentes-Raspall R, et al. J Neurooncol. 2011 Jan;101(1):117-23. doi: 10.1007/s11060-010-0240-7. Epub 2010 Jun 11. J Neurooncol. 2011. PMID: 20544374
A total of 493 new CNS cancer patients were registered during the study period: 49.3% astrocytic, 3.4% oligodendroglial and oligoastrocytic tumours, 2.6% ependimal tumours, 3.7% embryonal tumours, 0.2% choroid plexus and 41% without histological confir …
A total of 493 new CNS cancer patients were registered during the study period: 49.3% astrocytic, 3.4% oligodendroglial and oligoastrocyt …
Molecular neuropathology of low-grade gliomas and its clinical impact.
Riemenschneider MJ, Reifenberger G. Riemenschneider MJ, et al. Adv Tech Stand Neurosurg. 2010;35:35-64. doi: 10.1007/978-3-211-99481-8_2. Adv Tech Stand Neurosurg. 2010. PMID: 20102110 Review.
The term "low-grade glioma" refers to a heterogeneous group of slowly growing glial tumors corresponding histologically to World Health Organization (WHO) grade I or II. This group includes astrocytic, oligodendroglial, oligoastrocytic and ependymal tumor ent …
The term "low-grade glioma" refers to a heterogeneous group of slowly growing glial tumors corresponding histologically to World Heal …
H3K27me3 immunostaining is diagnostic and prognostic in diffuse gliomas with oligodendroglial or mixed oligoastrocytic morphology.
Ammendola S, Caldonazzi N, Simbolo M, Piredda ML, Brunelli M, Poliani PL, Pinna G, Sala F, Ghimenton C, Scarpa A, Barresi V. Ammendola S, et al. Virchows Arch. 2021 Nov;479(5):987-996. doi: 10.1007/s00428-021-03134-1. Epub 2021 Jun 24. Virchows Arch. 2021. PMID: 34165590 Free PMC article.
We aimed to assess the diagnostic and prognostic value of H3K27me3 immuno-expression in diffuse gliomas with oligodendroglial or mixed oligoastrocytic morphology. H3K27me3 immunostaining was performed in 69 diffuse gliomas with oligodendroglial (n = 62) or oligoastrocyt …
We aimed to assess the diagnostic and prognostic value of H3K27me3 immuno-expression in diffuse gliomas with oligodendroglial or mixed ol …
Initial chemotherapy in gliomatosis cerebri.
Sanson M, Cartalat-Carel S, Taillibert S, Napolitano M, Djafari L, Cougnard J, Gervais H, Laigle F, Carpentier A, Mokhtari K, Taillandier L, Chinot O, Duffau H, Honnorat J, Hoang-Xuan K, Delattre JY; ANOCEF group. Sanson M, et al. Neurology. 2004 Jul 27;63(2):270-5. doi: 10.1212/01.wnl.0000129985.39973.e4. Neurology. 2004. PMID: 15277619 Clinical Trial.
GC was initially present at diagnosis in 49 patients (primary GC), whereas 14 patients with a circumscribed glioma at onset developed secondary GC after a median follow-up period of 5.11 years. GC was classified based on the predominant tumor cells as astrocytic, oligodend …
GC was initially present at diagnosis in 49 patients (primary GC), whereas 14 patients with a circumscribed glioma at onset developed second …
Analysis of CASP8 D302H Gene Variants in Patients with Primary Brain Tumors.
Cacina C, Pence S, Turan S, Genc F, Ozdemir H, Kafadar A, Kaynar MY, Yaylim I. Cacina C, et al. In Vivo. 2015 Sep-Oct;29(5):601-4. In Vivo. 2015. PMID: 26359420
The present study was designed to investigate the possible role of CASP8 D302H gene polymorphism in the tumor development. MATERIALS AND METHODS: A total of 91 patients with brain tumors (including 39 meningioma and 52 glioma cases) and 114 healthy controls were inc …
The present study was designed to investigate the possible role of CASP8 D302H gene polymorphism in the tumor development. MATERIALS …
Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma-Tailored Gene Panel.
Zacher A, Kaulich K, Stepanow S, Wolter M, Köhrer K, Felsberg J, Malzkorn B, Reifenberger G. Zacher A, et al. Brain Pathol. 2017 Mar;27(2):146-159. doi: 10.1111/bpa.12367. Epub 2016 Apr 19. Brain Pathol. 2017. PMID: 26919320 Free PMC article.
These can refine tumor diagnostics and provide important prognostic and predictive information. ...Oligoastrocytic gliomas were genetically assigned to either of these groups. ...
These can refine tumor diagnostics and provide important prognostic and predictive information. ...Oligoastrocytic gliomas wer …
Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors.
Shukla B, Agarwal S, Suri V, Pathak P, Sharma MC, Gupta D, Sharma BS, Suri A, Halder A, Sarkar C. Shukla B, et al. Neurol India. 2009 Sep-Oct;57(5):559-66. doi: 10.4103/0028-3886.57795. Neurol India. 2009. PMID: 19934553 Free article.
CONCLUSION: Loss of 1p/19q is strongly associated with oligodendroglial phenotype, while astrocytic tumors are more likely to show p53 over-expression. p53 expression and 1p/19q status appear to be mutually exclusive....
CONCLUSION: Loss of 1p/19q is strongly associated with oligodendroglial phenotype, while astrocytic tumors are more likely to show p5 …
Molecular diagnostics as a tool to personalize treatment in adult glioma patients.
Jeuken JW, van der Maazen RW, Wesseling P. Jeuken JW, et al. Technol Cancer Res Treat. 2006 Jun;5(3):215-29. doi: 10.1177/153303460600500305. Technol Cancer Res Treat. 2006. PMID: 16700618 Free article. Review.
Gliomas, the most frequent primary brain tumors in humans, form a heterogeneous group, encompassing many different histological types and malignancy grades. ...After summarizing the most relevant genetic aberrations and pathways in these tumors detected up till now, …
Gliomas, the most frequent primary brain tumors in humans, form a heterogeneous group, encompassing many different histological types …
21 results